Roger Løvlie • 1971 • Torvastad • 10 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
R ROLOGEN AS	Managing Director/CEO	-	4,096,818	100 % directly
L LIANLO AS	Managing Director/CEO	1,223,471	1,026,399	100 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
R ROLOGEN AS	Chairman	-	4,096,818	100 % directly
L LIANLO AS	Chairman	1,223,471	1,026,399	100 % indirectly
C COLOALERT AS	Board Member	-	5,700,354	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Board Member	19,212,741	22,847,691	31.3 % indirectly
E EUROPEAN ONCOLOGY LAB AS	Board Member	33,159	-68,687	31.3 % indirectly
R ROGER LØVLIE GENECONSULT	Holder	-	-	-
T TORVASTAD ARENA AS	Deputy Chair	1,769,431	7,450,080	-
F FRIBU KARMØY	Board Member	-	-	-

Last update: Jan 7, 2025

Related industries5

Direct relationships5

DS
Dagfinn Steinar Øgreid1956
EUROPEAN ONCOLOGY LAB AS, COLOALERT AS, UNI TARGETING RESEARCH AS
HJ
Hans Johan Hekland1958
EUROPEAN ONCOLOGY LAB AS, COLOALERT AS, UNI TARGETING RESEARCH AS
AA
Arne Alf Haldorsen1948
TORVASTAD ARENA AS
KV
Kjetil Vikingstad1971
TORVASTAD ARENA AS
LØ
Lars Øystein Folkedal1969
FRIBU KARMØY

Shares owned by Roger Løvlie

Name	Share class	Total operating income	Total equity	Share
R ROLOGEN AS	Ordinære aksjer	0	4,096,818	100 % directly
L LIANLO AS		1,223,471	1,026,399	100 % indirectly
C COLOALERT AS		0	5,700,354	33.33 % indirectly
E EUROPEAN ONCOLOGY LAB AS		33,159	-68,687	31.3 % indirectly
U UNI TARGETING RESEARCH AS		19,212,741	22,847,691	31.3 % indirectly
B BRACOM AS		239,141,231	50,061,087	1.93 % indirectly
B BRACOM MICROTRENCHING AS		29,016,781	532,344	1.93 % indirectly
D DEEPX HEALTH AS	NO0010159700	792,936	141,278,563	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025